A Rat Migraine Model Did Not Establish Long-Term THC Treatment for Patients

Illustration of amber sample vials beside a laboratory analytical instrument

Repeated THC preserved a pain-related response in a female-rat migraine model without the worsening seen after morphine. That preclinical comparison does not establish long-term effectiveness or freedom from medication-overuse headache in human patients.

A model based on activity suppression

Researchers applied an irritant to the dura to produce migraine-like suppression of voluntary wheel running. They compared THC, morphine and vehicle, using restoration of running as a pain-related outcome. The animals could not report headache severity, disability or the symptoms used for a human diagnosis.

Repeated treatment produced different patterns

THC restored running after the irritant and retained that effect after repeated administration. Morphine’s benefit diminished, and prior morphine prolonged the irritant-related suppression compared with THC or vehicle. The authors interpreted the morphine pattern as tolerance and medication-overuse-headache-like behavior.

What the negative THC finding means

The tested THC regimen did not produce that same worsening. It does not demonstrate that every dose, duration or cannabis product is free of headache-related complications. Nor does preserved running on repeated tests establish sustained benefit over months or years.

The translational question

Only female rats and a particular induced-pain model were studied. Movement can be influenced by factors other than pain, making dose and behavioral controls important. The results justify further clinical investigation, but they do not compare THC with established human migraine strategies or validate routine long-term use. A treatment claim must retain the distinction between a promising animal endpoint and demonstrated patient benefit.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Kandasamy R; Dawson CT; Hilgendorf TN; Morgan MM. Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat. Behavioural pharmacology (2018). DOI: 10.1097/FBP.0000000000000382.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Did Mental Health Professionals Report After a Breathwork Workshop?

Ulrike Lueken and colleagues asked 48 mental health professionals to take part in a high-ventilation breathwork workshop and rate their experience. The participants reported altered states and also gave their judgments about possible therapeutic uses and risks. Those ratings describe the views of the workshop group. They do not measure…

Spread the love

Read Article: What Did Mental Health Professionals Report After a Breathwork Workshop?

What Changed on an Emotional Face Recognition Task After Psilocybin With Support?

In an open-label study, J. B. Stroud and colleagues found that people with treatment-resistant depression recognized facial emotions faster one month after receiving psilocybin with psychological support. Seventeen patients completed the task at baseline and follow-up. Sixteen untreated controls completed it on the same schedule. The researchers reported a group-by-time…

Spread the love

Read Article: What Changed on an Emotional Face Recognition Task After Psilocybin With Support?

What Did a Young-Adult CBD Survey Reveal About How Users Chose a Dose?

A survey of young adults asked how CBD users chose a dose. Their answers show why a product history needs more detail than a report of CBD use.

Spread the love

Read Article: What Did a Young-Adult CBD Survey Reveal About How Users Chose a Dose?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us